Voy is a UK weight loss provider offering Mounjaro and Wegovy through flexible multi-month plans, alongside a growing menopause service. It markets itself as the UK's number one weight loss provider on Trustpilot — a claim based on review volume and rating rather than clinical outcomes, but one that reflects genuinely strong patient sentiment. This review evaluates Voy across pricing structure, medications, eligibility, support, and how it compares within the UK market.

Quick Takeaway:

• UK private weight loss provider offering Mounjaro and Wegovy on flexible 3- or 6-month plans
• Markets itself as the UK's No. 1 weight loss provider on Trustpilot
• Multi-month plans are the core pricing mechanism, designed to reduce the monthly rate
• Also operates a menopause service with plans published from £79/month including blood tests and unlimited support
• Best for UK patients who want committed multi-month pricing and strong customer service

Looking for a Better Alternative?

Voy performs well within the UK market, and we benchmark every provider against the highest-rated service we track. CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy overall, combining competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

CoreAge Rx serves patients in the United States. For UK readers, Voy's direct competitors are Numan, Juniper UK, and Second Nature.

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. Available to patients in the United States.

What Is Voy?

Voy is a UK digital health company describing itself as a proactive companion for healthy living, with weight loss as its flagship service and menopause care as a growing second line. It offers Mounjaro and Wegovy on private prescription with clinical oversight, delivered through an app-based programme.

Its commercial differentiator is plan structure. Rather than pure month-to-month billing, Voy leads with flexible 3- or 6-month plans explicitly framed as a way to reduce cost — a model that suits patients committing to a full titration cycle and penalises those who want to try a month and stop.

Voy publishes comparison content against its main UK rivals, including direct Voy-versus-Juniper and Voy-versus-Numan pieces. Provider-written comparisons are marketing rather than independent analysis, but they are useful for understanding how each company positions itself.

How Voy Works

1. Complete the online consultation. Health history, BMI, medications, and goals.
2. Clinical review. A UK clinician assesses suitability against private prescribing criteria.
3. Choose a plan. 3-month or 6-month plans structured to reduce the monthly cost.
4. Delivery. Medication dispensed by a UK pharmacy partner and delivered to your address.
5. Ongoing support. Regular check-ins, progress tracking, and dose management through the app.

Medication Options and Pricing

Important: Multi-month plans are the mechanism by which most UK providers, Voy included, offer lower headline prices. They are good value if you complete the course and poor value if side effects, cost, or circumstances cause you to stop early. Roughly speaking, commit to the plan length you are confident you will finish, not the one with the best per-month figure.

Voy has published guidance on the 2025 UK Mounjaro price increase, which followed Eli Lilly raising its UK list price. That change reset pricing across every UK private provider, so any figure predating it should be treated as historical.

Check Voy Pricing

UK weight loss programme with Mounjaro and Wegovy on flexible 3- or 6-month plans, with clinical oversight and ongoing support.

Eligibility, Providers, and Lab Requirements

Voy applies UK private prescribing criteria: BMI 30 or above, or 27 or above with a weight-related condition. Assessments are reviewed by UK clinicians, and the service operates within GPhC and CQC frameworks applicable to UK online providers.

Voy's menopause service explicitly includes blood tests in its published pricing, which suggests a reasonable clinical posture; the weight service's laboratory requirements depend on your clinical picture.

Contraindications follow the class: medullary thyroid carcinoma history, MEN2, pregnancy and breastfeeding, and hypersensitivity.

Pharmacy Fulfilment and Shipping

Medication is dispensed by UK-registered pharmacy partners and delivered to your address. Injection pens require refrigeration before first use. As with all UK providers, check pen condition on arrival and report any concerns immediately rather than after your next dose is due.

Ongoing Support, Nutrition, and Coaching

Voy's programme includes:

• Regular clinical check-ins during titration
• Progress tracking through the app
• Patient support that features prominently in its Trustpilot reviews
• Educational content on medication, side effects, and lifestyle
• A refer-a-friend scheme that patients report using to reduce costs

Patient testimonials repeatedly emphasise the check-in cadence and responsiveness rather than curriculum depth. Voy's support is relational rather than programmatic — closer to attentive customer service than to a structured behavioural intervention like Second Nature.

Cancellation, Refunds, Insurance, and Costs

Multi-month plans are the main consideration. Once medication has been dispensed under a plan, refunds are limited — prescription medicines cannot be returned. Cancellation generally stops future dispensing rather than refunding what has already shipped.

Voy is a private service. The NHS does not fund private weight loss providers, and UK private medical insurance rarely covers weight loss medication. If you meet NHS criteria for tirzepatide, that route is dramatically cheaper; ask your GP first.

Pros and Cons

Pros

• Strong patient sentiment and Trustpilot standing
• Flexible 3- and 6-month plans that genuinely reduce the monthly rate
• Both Mounjaro and Wegovy available
• Responsive support that patients consistently praise
• Refer-a-friend discounts that meaningfully reduce cost
• Separate menopause service with transparent inclusive pricing

Cons

• Multi-month commitment is the route to the best pricing
• Limited flexibility if you need to stop mid-plan
• Support is service-led rather than a structured behavioural programme
• Not covered by the NHS or most private insurance
• Provider-written comparison content should be read as marketing

Best Use Cases and Limitations

Best for: UK patients confident they will complete a 3- or 6-month course, who value responsive customer service, and who want a straightforward app-based programme.

Limitations: Patients who want month-to-month flexibility, who want deep dietitian-led coaching, or who may qualify for NHS treatment.

Alternatives to Voy

Frequently Asked Questions

How much does Voy cost?

Voy prices Mounjaro and Wegovy through flexible 3- or 6-month plans designed to reduce the monthly rate compared with shorter commitments. Its separate menopause service is published from £79 per month including blood tests and unlimited support. Verify current weight loss pricing for your dose directly, as UK pricing changed after the 2025 Mounjaro list price increase.

Is Voy really the UK's number one weight loss provider?

Voy markets itself as the UK's No. 1 weight loss provider on Trustpilot. That reflects review volume and rating rather than independently verified clinical outcomes, so treat it as a strong customer satisfaction signal rather than a measure of effectiveness.

What medications does Voy offer?

Mounjaro (tirzepatide) and Wegovy (semaglutide), both weekly injections, on private prescription following clinical review.

Do I have to commit to a multi-month plan?

Voy's pricing is built around flexible 3- and 6-month plans, which are how it delivers savings. Commit to the length you are confident you will complete, since dispensed prescription medication generally cannot be refunded.

Does Voy offer coaching?

Voy provides regular check-ins, progress tracking, and responsive support rather than a structured dietitian-led behavioural curriculum. For deeper coaching, Second Nature or Numan are closer fits.

Can I get Mounjaro on the NHS instead?

Possibly. NICE has recommended tirzepatide for weight management within specific criteria, and NHS access has been rolled out in phases prioritised by clinical need. Speak to your GP about whether you qualify before paying privately.

Bottom Line

Voy has built genuine goodwill in the UK market, and its Trustpilot standing reflects real patient satisfaction with responsiveness and communication. The multi-month plan structure is honest about what it is — a discount for commitment.

Strengths: excellent patient sentiment, flexible multi-month savings, both major medications, responsive support, referral discounts.

Drawbacks: commitment required for best pricing, limited mid-plan flexibility, service-led rather than programme-led support, no NHS or insurance coverage.

Best for: UK patients ready to commit to a full titration course.

Skip if: you want month-to-month flexibility or intensive behavioural coaching.

The most expensive GLP-1 course is the one you abandon in month two. Choose your plan length honestly — and check your NHS eligibility before paying privately.

US readers: CoreAge Rx offers all-in monthly pricing from $179–$399 including medication and provider messaging, with 12–24 hour approvals. Save up to $200 on your first three months.

Medical disclaimer: Informational only, not medical advice. Mounjaro and Wegovy are prescription medicines with real risks and contraindications. Consult a qualified healthcare professional before starting or changing treatment. UK pricing changes frequently and should be verified directly.

Sources: Voy published medication, pricing, and comparison pages; NICE obesity management guidance; MHRA medicine safety information.

Date reviewed: August 2026